메뉴 건너뛰기




Volumn 375, Issue 1, 2016, Pages 162-171

Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells

Author keywords

Apoptosis; Breast cancer; Mevalonate pathway; Rho GTPases; Statins; Zoledronic acid

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; PROTEIN CDC42; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ROSUVASTATIN; SIMVASTATIN; ZOLEDRONIC ACID; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CASP3 PROTEIN, HUMAN; CASP7 PROTEIN, HUMAN; CASPASE 3; CASPASE 7; IMIDAZOLE DERIVATIVE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

EID: 84960448650     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.03.004     Document Type: Article
Times cited : (40)

References (60)
  • 3
    • 0036675220 scopus 로고    scopus 로고
    • Metastasis to bone: causes, consequences and therapeutic opportunities
    • Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2002, 2:584-593. 10.1038/nrc867.
    • (2002) Nat. Rev. Cancer , vol.2 , pp. 584-593
    • Mundy, G.R.1
  • 4
    • 84947486728 scopus 로고    scopus 로고
    • The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases
    • Mariz K., Ingolf J.-B., Daniel H., Teresa N.J., Erich-Franz S. The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases. Clin. Exp. Metastasis 2015, 32:857-866. 10.1007/s10585-015-9750-1.
    • (2015) Clin. Exp. Metastasis , vol.32 , pp. 857-866
    • Mariz, K.1    Ingolf, J.-B.2    Daniel, H.3    Teresa, N.J.4    Erich-Franz, S.5
  • 7
    • 36649001116 scopus 로고    scopus 로고
    • Bisphosphonates: reducing the risk of skeletal complications from bone metastasis
    • Costa L. Bisphosphonates: reducing the risk of skeletal complications from bone metastasis. Breast 2007, 16(Suppl. 3):S16-S20. 10.1016/j.breast.2007.10.005.
    • (2007) Breast , vol.16 , pp. S16-S20
    • Costa, L.1
  • 8
    • 84863317657 scopus 로고    scopus 로고
    • Novel aspects of mevalonate pathway inhibitors as antitumor agents
    • Thurnher M., Nussbaumer O., Gruenbacher G. Novel aspects of mevalonate pathway inhibitors as antitumor agents. Clin. Cancer Res 2012, 18:3524-3531. 10.1158/1078-0432.CCR-12-0489.
    • (2012) Clin. Cancer Res , vol.18 , pp. 3524-3531
    • Thurnher, M.1    Nussbaumer, O.2    Gruenbacher, G.3
  • 9
    • 0036488510 scopus 로고    scopus 로고
    • RHO-GTPases and cancer
    • Sahai E., Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2002, 2:133-142. 10.1038/nrc725.
    • (2002) Nat. Rev. Cancer , vol.2 , pp. 133-142
    • Sahai, E.1    Marshall, C.J.2
  • 10
    • 0141756144 scopus 로고    scopus 로고
    • Role of Rho-family proteins in cell adhesion and cancer
    • Malliri A., Collard J.G. Role of Rho-family proteins in cell adhesion and cancer. Curr. Opin. Cell Biol 2003, 15:583-589. 10.1016/S0955-0674(03)00098-X.
    • (2003) Curr. Opin. Cell Biol , vol.15 , pp. 583-589
    • Malliri, A.1    Collard, J.G.2
  • 11
    • 1642304545 scopus 로고    scopus 로고
    • Altered Rho GTPase signaling pathways in breast cancer cells
    • Burbelo P., Wellstein A., Pestell R.G. Altered Rho GTPase signaling pathways in breast cancer cells. Breast Cancer Res. Treat 2004, 84:43-48. 10.1023/B:BREA.0000018422.02237.f9.
    • (2004) Breast Cancer Res. Treat , vol.84 , pp. 43-48
    • Burbelo, P.1    Wellstein, A.2    Pestell, R.G.3
  • 13
    • 84870520448 scopus 로고    scopus 로고
    • Targeting tumor cell metabolism with statins
    • Clendening J.W., Penn L.Z. Targeting tumor cell metabolism with statins. Oncogene 2012, 31:4967-4978. 10.1038/onc.2012.6.
    • (2012) Oncogene , vol.31 , pp. 4967-4978
    • Clendening, J.W.1    Penn, L.Z.2
  • 14
    • 0036239832 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
    • Wong W.W.L., Dimitroulakos J., Minden M.D., Penn L.Z. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund, U.K. 2002, 16:508-519. 10.1038/sj.leu.2402476.
    • (2002) Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund, U.K. , vol.16 , pp. 508-519
    • Wong, W.W.L.1    Dimitroulakos, J.2    Minden, M.D.3    Penn, L.Z.4
  • 15
    • 0026607503 scopus 로고
    • Cholesterol inhibition, cancer, and chemotherapy
    • Buchwald H. Cholesterol inhibition, cancer, and chemotherapy. Lancet (London, England). 1992, 339:1154-1156.
    • (1992) Lancet (London, England). , vol.339 , pp. 1154-1156
    • Buchwald, H.1
  • 16
    • 84862908644 scopus 로고    scopus 로고
    • Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
    • Freed-Pastor W.A., Mizuno H., Zhao X., Langerød A., Moon S.-H., Rodriguez-Barrueco R., et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 2012, 148:244-258. 10.1016/j.cell.2011.12.017.
    • (2012) Cell , vol.148 , pp. 244-258
    • Freed-Pastor, W.A.1    Mizuno, H.2    Zhao, X.3    Langerød, A.4    Moon, S.-H.5    Rodriguez-Barrueco, R.6
  • 19
    • 33645047418 scopus 로고    scopus 로고
    • The role of statins in cancer therapy
    • Hindler K., Cleeland C.S., Rivera E., Collard C.D. The role of statins in cancer therapy. Oncologist 2006, 11:306-315. 10.1634/theoncologist.11-3-306.
    • (2006) Oncologist , vol.11 , pp. 306-315
    • Hindler, K.1    Cleeland, C.S.2    Rivera, E.3    Collard, C.D.4
  • 20
    • 84887410335 scopus 로고    scopus 로고
    • Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates
    • Gronich N., Rennert G. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat. Rev. Clin. Oncol 2013, 10:625-642. 10.1038/nrclinonc.2013.169.
    • (2013) Nat. Rev. Clin. Oncol , vol.10 , pp. 625-642
    • Gronich, N.1    Rennert, G.2
  • 21
    • 84904960449 scopus 로고    scopus 로고
    • Mechanisms of action of bisphosphonates in oncology: a scientific concept evolving from antiresorptive to anticancer activities
    • Clézardin P. Mechanisms of action of bisphosphonates in oncology: a scientific concept evolving from antiresorptive to anticancer activities. Bonekey Rep 2013, 2:267. 10.1038/bonekey.2013.1.
    • (2013) Bonekey Rep , vol.2 , pp. 267
    • Clézardin, P.1
  • 22
    • 78650304661 scopus 로고    scopus 로고
    • Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class
    • Clézardin P. Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class. Bone 2011, 48:71-79. 10.1016/j.bone.2010.07.016.
    • (2011) Bone , vol.48 , pp. 71-79
    • Clézardin, P.1
  • 23
    • 0032491037 scopus 로고    scopus 로고
    • Reduction in new metastases in breast cancer with adjuvant clodronate treatment
    • Diel I.J., Solomayer E.F., Costa S.D., Gollan C., Goerner R., Wallwiener D., et al. Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N. Engl. J. Med 1998, 339:357-363. 10.1056/NEJM199808063390601.
    • (1998) N. Engl. J. Med , vol.339 , pp. 357-363
    • Diel, I.J.1    Solomayer, E.F.2    Costa, S.D.3    Gollan, C.4    Goerner, R.5    Wallwiener, D.6
  • 24
    • 51349163043 scopus 로고    scopus 로고
    • Bisphosphonates: mechanism of action and role in clinical practice
    • Drake M.T., Clarke B.L., Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin. Proc 2008, 83:1032-1045. 10.4065/83.9.1032.
    • (2008) Mayo Clin. Proc , vol.83 , pp. 1032-1045
    • Drake, M.T.1    Clarke, B.L.2    Khosla, S.3
  • 25
    • 84856848340 scopus 로고    scopus 로고
    • Zoledronic acid in breast cancer: latest findings and interpretations
    • Gnant M. Zoledronic acid in breast cancer: latest findings and interpretations. Ther. Adv. Med. Oncol 2011, 3:293-301. 10.1177/1758834011420599.
    • (2011) Ther. Adv. Med. Oncol , vol.3 , pp. 293-301
    • Gnant, M.1
  • 27
    • 84882297750 scopus 로고    scopus 로고
    • Effect of adjuvant bisphosphonates on disease-free survival in early breast cancer: retrospective analysis results in an unselected single-center cohort
    • Hadji P., Frank M., Jakob A., Siebers J.W. Effect of adjuvant bisphosphonates on disease-free survival in early breast cancer: retrospective analysis results in an unselected single-center cohort. J. Bone Oncol 2013, 2:2-10. 10.1016/j.jbo.2013.01.001.
    • (2013) J. Bone Oncol , vol.2 , pp. 2-10
    • Hadji, P.1    Frank, M.2    Jakob, A.3    Siebers, J.W.4
  • 28
    • 84864031857 scopus 로고    scopus 로고
    • Statins and cancer: current and future prospects
    • Osmak M. Statins and cancer: current and future prospects. Cancer Lett 2012, 324:1-12. 10.1016/j.canlet.2012.04.011.
    • (2012) Cancer Lett , vol.324 , pp. 1-12
    • Osmak, M.1
  • 29
    • 67650767002 scopus 로고    scopus 로고
    • Adverse effects of bisphosphonates: implications for osteoporosis management
    • quiz 638
    • Kennel K.A., Drake M.T. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin. Proc 2009, 84:632-637. quiz 638. 10.4065/84.7.632.
    • (2009) Mayo Clin. Proc , vol.84 , pp. 632-637
    • Kennel, K.A.1    Drake, M.T.2
  • 30
    • 84948380673 scopus 로고    scopus 로고
    • Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins
    • Göbel A., Browne A.J., Thiele S., Rauner M., Hofbauer L.C., Rachner T.D. Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins. Breast Cancer Res. Treat 2015, 623-631. 10.1007/s10549-015-3624-8.
    • (2015) Breast Cancer Res. Treat , pp. 623-631
    • Göbel, A.1    Browne, A.J.2    Thiele, S.3    Rauner, M.4    Hofbauer, L.C.5    Rachner, T.D.6
  • 31
    • 81255185444 scopus 로고    scopus 로고
    • Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors
    • Berndt N., Sebti S.M. Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors. Nat. Protoc 2011, 6:1775-1791. 10.1038/nprot.2011.387.
    • (2011) Nat. Protoc , vol.6 , pp. 1775-1791
    • Berndt, N.1    Sebti, S.M.2
  • 32
    • 84901653151 scopus 로고    scopus 로고
    • Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin
    • Benad-Mehner P., Thiele S., Rachner T.D., Göbel A., Rauner M., Hofbauer L.C. Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin. J. Bone Oncol 2014, 3:18-24. 10.1016/j.jbo.2013.11.001.
    • (2014) J. Bone Oncol , vol.3 , pp. 18-24
    • Benad-Mehner, P.1    Thiele, S.2    Rachner, T.D.3    Göbel, A.4    Rauner, M.5    Hofbauer, L.C.6
  • 33
    • 84901672375 scopus 로고    scopus 로고
    • Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells
    • Wilke M., Göbel A., Rauner M., Benad-Mehner P., Schütze N., Füssel S., et al. Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells. J. Bone Oncol 2014, 3:10-17. 10.1016/j.jbo.2014.02.001.
    • (2014) J. Bone Oncol , vol.3 , pp. 10-17
    • Wilke, M.1    Göbel, A.2    Rauner, M.3    Benad-Mehner, P.4    Schütze, N.5    Füssel, S.6
  • 34
    • 0034912833 scopus 로고    scopus 로고
    • A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro
    • Yoneda T., Williams P.J., Hiraga T., Niewolna M., Nishimura R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J. Bone Miner. Res 2001, 16:1486-1495. 10.1359/jbmr.2001.16.8.1486.
    • (2001) J. Bone Miner. Res , vol.16 , pp. 1486-1495
    • Yoneda, T.1    Williams, P.J.2    Hiraga, T.3    Niewolna, M.4    Nishimura, R.5
  • 35
    • 0036792257 scopus 로고    scopus 로고
    • Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo
    • Bendre M.S., Gaddy-Kurten D., Mon-Foote T., Akel N.S., Skinner R.A., Nicholas R.W., et al. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 2002, 62:5571-5579.
    • (2002) Cancer Res , vol.62 , pp. 5571-5579
    • Bendre, M.S.1    Gaddy-Kurten, D.2    Mon-Foote, T.3    Akel, N.S.4    Skinner, R.A.5    Nicholas, R.W.6
  • 36
    • 1042304249 scopus 로고    scopus 로고
    • Models of breast cancer: is merging human and animal models the future?
    • Kim J.B., O'Hare M.J., Stein R. Models of breast cancer: is merging human and animal models the future?. Breast Cancer Res 2004, 6:22-30. 10.1186/bcr645.
    • (2004) Breast Cancer Res , vol.6 , pp. 22-30
    • Kim, J.B.1    O'Hare, M.J.2    Stein, R.3
  • 37
    • 80053426842 scopus 로고    scopus 로고
    • Review series Targeted therapies for breast cancer
    • Higgins M.J., Baselga J. Review series Targeted therapies for breast cancer. J. Clin. Invest 2011, 121:3797-3803. 10.1172/JCI57152.with.
    • (2011) J. Clin. Invest , vol.121 , pp. 3797-3803
    • Higgins, M.J.1    Baselga, J.2
  • 38
    • 59449084603 scopus 로고    scopus 로고
    • Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
    • Borgquist S., Jögi A., Pontén F., Rydén L., Brennan D.J., Jirström K. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer. Breast Cancer Res 2008, 10:R79. 10.1186/bcr2146.
    • (2008) Breast Cancer Res , vol.10 , pp. R79
    • Borgquist, S.1    Jögi, A.2    Pontén, F.3    Rydén, L.4    Brennan, D.J.5    Jirström, K.6
  • 39
    • 84879411965 scopus 로고    scopus 로고
    • Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
    • Bjarnadottir O., Romero Q., Bendahl P.O., Jirström K., Rydén L., Loman N., et al. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Breast Cancer Res. Treat 2013, 138:499-508. 10.1007/s10549-013-2473-6.
    • (2013) Breast Cancer Res. Treat , vol.138 , pp. 499-508
    • Bjarnadottir, O.1    Romero, Q.2    Bendahl, P.O.3    Jirström, K.4    Rydén, L.5    Loman, N.6
  • 40
    • 33747600872 scopus 로고    scopus 로고
    • Synergistic antimyeloma effects of zoledronate and simvastatin
    • Schmidmaier R., Simsek M., Baumann P., Emmerich B., Meinhardt G. Synergistic antimyeloma effects of zoledronate and simvastatin. Anticancer Drugs 2006, 17:621-629. 10.1097/01.cad.0000215058.85813.02.
    • (2006) Anticancer Drugs , vol.17 , pp. 621-629
    • Schmidmaier, R.1    Simsek, M.2    Baumann, P.3    Emmerich, B.4    Meinhardt, G.5
  • 41
    • 84863717286 scopus 로고    scopus 로고
    • Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice
    • Ottewell P.D., Brown H.K., Jones M., Rogers T.L., Cross S.S., Brown N.J., et al. Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice. Breast Cancer Res. Treat 2012, 133:523-536. 10.1007/s10549-011-1782-x.
    • (2012) Breast Cancer Res. Treat , vol.133 , pp. 523-536
    • Ottewell, P.D.1    Brown, H.K.2    Jones, M.3    Rogers, T.L.4    Cross, S.S.5    Brown, N.J.6
  • 42
    • 70350234896 scopus 로고    scopus 로고
    • Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone
    • Ottewell P.D., Woodward J.K., Lefley D.V., Evans C.A., Coleman R.E., Holen I. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Mol. Cancer Ther 2009, 8:2821-2832. 10.1158/1535-7163.MCT-09-0462.
    • (2009) Mol. Cancer Ther , vol.8 , pp. 2821-2832
    • Ottewell, P.D.1    Woodward, J.K.2    Lefley, D.V.3    Evans, C.A.4    Coleman, R.E.5    Holen, I.6
  • 43
    • 73549086519 scopus 로고    scopus 로고
    • Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model
    • Ottewell P.D., Lefley D.V., Cross S.S., Evans C.A., Coleman R.E., Holen I. Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model. Int. J. Cancer 2010, 126:522-532. 10.1002/ijc.24756.
    • (2010) Int. J. Cancer , vol.126 , pp. 522-532
    • Ottewell, P.D.1    Lefley, D.V.2    Cross, S.S.3    Evans, C.A.4    Coleman, R.E.5    Holen, I.6
  • 44
    • 84977897354 scopus 로고    scopus 로고
    • Review series introduction
    • Polyak K. Review series introduction. Heterogeneity in breast cancer 2011, 121:2011-2013. 10.1172/JCI60534.3786.
    • (2011) Heterogeneity in breast cancer , vol.121 , pp. 2011-2013
    • Polyak, K.1
  • 45
    • 84860702956 scopus 로고    scopus 로고
    • The differential effects of statins on the metastatic behaviour of prostate cancer
    • Brown M., Hart C., Tawadros T., Ramani V., Sangar V., Lau M., et al. The differential effects of statins on the metastatic behaviour of prostate cancer. Br. J. Cancer 2012, 106:1689-1696. 10.1038/bjc.2012.138.
    • (2012) Br. J. Cancer , vol.106 , pp. 1689-1696
    • Brown, M.1    Hart, C.2    Tawadros, T.3    Ramani, V.4    Sangar, V.5    Lau, M.6
  • 46
    • 0038792653 scopus 로고    scopus 로고
    • New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects
    • Denoyelle C., Hong L., Vannier J.-P., Soria J., Soria C. New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects. Br. J. Cancer 2003, 88:1631-1640. 10.1038/sj.bjc.6600925.
    • (2003) Br. J. Cancer , vol.88 , pp. 1631-1640
    • Denoyelle, C.1    Hong, L.2    Vannier, J.-P.3    Soria, J.4    Soria, C.5
  • 47
    • 0142245593 scopus 로고    scopus 로고
    • Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels
    • van de Donk N.W.C.J., Kamphuis M.M.J., van Kessel B., Lokhorst H.M., Bloem A.C. Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels. Blood 2003, 102:3354-3362. 10.1182/blood-2003-03-0970.
    • (2003) Blood , vol.102 , pp. 3354-3362
    • van de Donk, N.W.C.J.1    Kamphuis, M.M.J.2    van Kessel, B.3    Lokhorst, H.M.4    Bloem, A.C.5
  • 50
    • 77956459044 scopus 로고    scopus 로고
    • Rac and Rho GTPases in cancer cell motility control
    • Parri M., Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun. Signal 2010, 8:23. 10.1186/1478-811X-8-23.
    • (2010) Cell Commun. Signal , vol.8 , pp. 23
    • Parri, M.1    Chiarugi, P.2
  • 51
    • 33646269011 scopus 로고    scopus 로고
    • Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases
    • Dunford J.E., Rogers M.J., Ebetino F.H., Phipps R.J., Coxon F.P. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases. J. Bone Miner. Res 2006, 21:684-694. 10.1359/JBMR.060118.
    • (2006) J. Bone Miner. Res , vol.21 , pp. 684-694
    • Dunford, J.E.1    Rogers, M.J.2    Ebetino, F.H.3    Phipps, R.J.4    Coxon, F.P.5
  • 53
    • 84879711057 scopus 로고    scopus 로고
    • Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases
    • Zhu Y., Casey P.J., Kumar A.P., Pervaiz S. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases. Cell Death Dis 2013, 4:e568. 10.1038/cddis.2013.103.
    • (2013) Cell Death Dis , vol.4
    • Zhu, Y.1    Casey, P.J.2    Kumar, A.P.3    Pervaiz, S.4
  • 54
  • 55
    • 0030798405 scopus 로고    scopus 로고
    • The small GTPase Cdc42 initiates an apoptotic signaling pathway in Jurkat T lymphocytes
    • Chuang T.H., Hahn K.M., Lee J.D., Danley D.E., Bokoch G.M. The small GTPase Cdc42 initiates an apoptotic signaling pathway in Jurkat T lymphocytes. Mol. Biol. Cell 1997, 8:1687-1698.
    • (1997) Mol. Biol. Cell , vol.8 , pp. 1687-1698
    • Chuang, T.H.1    Hahn, K.M.2    Lee, J.D.3    Danley, D.E.4    Bokoch, G.M.5
  • 56
    • 84902612645 scopus 로고    scopus 로고
    • Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) induces apoptosis in LNCaP prostate cancer cells
    • Augspach A., List J.H., Wolf P., Bielek H., Schwan C., Elsässer-Beile U., et al. Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) induces apoptosis in LNCaP prostate cancer cells. Toxins (Basel) 2013, 5:2241-2257. 10.3390/toxins5112241.
    • (2013) Toxins (Basel) , vol.5 , pp. 2241-2257
    • Augspach, A.1    List, J.H.2    Wolf, P.3    Bielek, H.4    Schwan, C.5    Elsässer-Beile, U.6
  • 58
    • 84868019264 scopus 로고    scopus 로고
    • Targeting of Rac GTPases blocks the spread of intact human breast cancer
    • doi:520 [pii]
    • Katz E., Sims A.H., Sproul D., Caldwell H., Dixon M.J., Meehan R.R., et al. Targeting of Rac GTPases blocks the spread of intact human breast cancer. Oncotarget 2012, 3:608-619. doi:520 [pii].
    • (2012) Oncotarget , vol.3 , pp. 608-619
    • Katz, E.1    Sims, A.H.2    Sproul, D.3    Caldwell, H.4    Dixon, M.J.5    Meehan, R.R.6
  • 59
    • 18644373689 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases
    • Chen T., Berenson J., Vescio R., Swift R., Gilchick A., Goodin S., et al. Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. J. Clin. Pharmacol 2002, 42:1228. 10.1177/0091270002238765.
    • (2002) J. Clin. Pharmacol , vol.42 , pp. 1228
    • Chen, T.1    Berenson, J.2    Vescio, R.3    Swift, R.4    Gilchick, A.5    Goodin, S.6
  • 60
    • 83455163746 scopus 로고    scopus 로고
    • Pharmacological actions of statins: a critical appraisal in the management of cancer
    • Gazzerro P., Proto M.C., Gangemi G., Malfitano A.M., Ciaglia E., Pisanti S., et al. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol. Rev 2012, 64:102-146. 10.1124/pr.111.004994.
    • (2012) Pharmacol. Rev , vol.64 , pp. 102-146
    • Gazzerro, P.1    Proto, M.C.2    Gangemi, G.3    Malfitano, A.M.4    Ciaglia, E.5    Pisanti, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.